Evidence map›Paper›PMID 41578332›Full record

ArticleInternational journal of health geographics2026

Spatial downscaling of multivariate disease risk.

David Payares-Garcia, Frank Osei, Jorge Mateu, Alfred Stein

Abstract read
In one paragraph

Article in International journal of health geographics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

David Payares-GarciaITC Faculty Geo-Information Science and Earth Observation, University of Twente, Enschede, The Netherlands. d.e.payaresgarcia@utwente.nl.
Frank OseiITC Faculty Geo-Information Science and Earth Observation, University of Twente, Enschede, The Netherlands.
Jorge MateuDepartment of Mathematics, University Jaume I, Castellón, Spain.
Alfred SteinITC Faculty Geo-Information Science and Earth Observation, University of Twente, Enschede, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Downscaling areal health data to a finer resolution is important for understanding the intricate spatial patterns of disease. It helps to identify shared risk factors and to develop targeted public health interventions. This paper introduces Area-to-Area (ATA) and Area-to-Point (ATP) Poisson cokriging for downscaling spatial disease risks from aggregated areal data. The methodology addresses key challenges by incorporating correlation between the diseases, adjusting for population heterogeneity, and the varying shapes and sizes of the spatial entities. Simulation studies demonstrate the superior performance of ATA and ATP Poisson cokriging compared to their univariate counterparts. We achieved lower mean squared prediction errors and better preserved small-scale spatial variations. The methods are applied to COVID-19 and asthma occurrences in Bogota, Colombia. They reveal more detailed hotspots and coldspots and refined estimates of COVID-19 risk by leveraging its correlation with asthma. Our methods offer advantages in multivariate disease mapping by enabling more accurate risk assessment, improved small-area estimation, and enhanced understanding of spatial disease patterns. Their ability to downscale risks for multiple diseases simultaneously provides valuable insights for targeted public health interventions and resource allocation.

Indexed as

AsthmaCOVID-19Pneumonia, ViralSpatial AnalysisColombiaHumansMultivariate AnalysisPandemicsRisk AssessmentRisk FactorsSARS-CoV-2CokrigingCountsDisease mappingDownscalingMultivariate

Identifiers

PMID41578332
PMCPMC12895962

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.